NanoSystems Biology Cancer Center 2
California Institute of Technology
Technologies developed by the California Institute of Technology CCNE provide a pathway for the early detection and informative diagnosis of melanoma, glioblastoma, and ovarian cancers through in vitro diagnostics and in vivo molecular imaging. Direct applications to targeted therapies, including molecularly targeted therapies, adoptive T cell immunotherapies and siRNA therapies are explored within this CCNE.
James Heath, Ph.D.
Leroy Hood, M.D., Ph.D.
Michael Phelps, Ph.D.
- Project 1: Organ-Specific, Blood Protein Biomarkers for an Informative Diagnosis of Brain and Ovarian Cancers: Technologies for Rapid Evaluation, Validation, and Clinical Translation
- Project 2: Novel Nanotechnologies and Molecular Imaging Approaches for Cancer Immunotherapy
- Project 3: Molecular Imaging of Metabolic Switches in Malignant Transformations
- Project 4: Nanotechnologies for Assessing Molecular Heterogeneity and Therapeutic Resistance in GBM Patients
- Project 5: RNA-Interference-Based Nanotherapeutics
- Core A: UCLA Institute for Molecular Medicine
- Core B: Nanofabrication and Nanomaterials Characterization
- Core C: Systems Biology